Standards > terminology artifact > DOI:10.25504/FAIRsharing.ypfgeq

ready Translational Medicine Ontology


General Information
This project focuses on the development of a high level patient-centric ontology for the pharmaceutical industry. The ontology should enable silos in discovery research, hypothesis management, experimental studies, compounds, formulation, drug development, market size, competitive data, population data, etc. to be brought together. This would enable scientists to answer new questions, and to answer existing scientific questions more quickly. This will help pharmaceutical companies to model patient-centric information, which is essential for the tailoring of drugs, and for early detection of compounds that may have sub-optimal safety profiles. The ontology should link to existing publicly available domain ontologies.

How to cite this record: TMO; Translational Medicine Ontology; DOI:; Last edited: Feb. 22, 2018, 2:05 p.m.; Last accessed: Mar 19 2018 5:04 a.m.

Record updated: Jan. 18, 2017, 3:38 p.m. by The FAIRsharing Team.


No support information provided.

Additional Information

External Links


    No tools defined


No XSD schemas defined


No publications available

TMO Ontology Display

View in BioPortal.

Disclaimer: This widget assumes the availability of the ontology resources in the NCBO BioPortal.

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

No semantic standards defined

Models and Formats

No syntax standards defined

Implementing Databases (0)

No Related Databases

Implementing Policies

This record is not implemented by any policy.


Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.